HLA-C and acute myeloid leukemia: Han’s research also revealed that AML patients with specific HLA-C genotypes (C1C1 and C1C2) were unresponsive to platelet transfusions from donors with C2C2 genotypes, highlighting the connection between HLA-C genotype and platelet transfusion efficacy [24].